1Rodrigo Tapia JP, Gareia Gonzalez LA, Martinez Sanchez JA, et al. CCND1 oneogane amplification and cellular DNA oontent in squarnous cell carcinomas of the head and neek[J ]. Aeta Otorrinolaringol Esp, 2001, 52(7): 539-543.
2Waiters AD, Latif Z, Forsyth A, et al. Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer[J ]. Br J Cancer, 2002, 87(6): 654-658.
3Dubus P, Young P, Beylot Barry M, et al. Value of interphase FISH for the diagnosis of t ( 11 : 14 ) ( q13 ; q32 ) on skin lesions of mantle cell lymphoma[J]. Am J Clin Pathol, 2002, 118(6): 832-841.
4Koiso H, Tsukamoto N, Miyawaki S, et al. Quantitative analysis of Cyclin D1 and CD23 expression in mantle cell lymphoma and Bchronic lymphocytic leukemia [ J ]. Leuk Res, 2002, 26 (9) : 809-815.
5Zhang YJ, Chen SY, Chen CJ, et al. Polymorphisms in cyclin D1 gene and hepatocellular carcinoma[J]. Mol Carcinog, 2002, 33(2):125-129.
6Zheng Y, Shen H, Sturgis EM, et al. Cyclin D1 polymorphism and risk for squarnous cell carcinoma of the head and neck: a case-control study[J]. Carcinogenesis, 2001, 22(8): 1195-1199.
7Holley SL, Parkes G, Matthias C, et al. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck[J]. Am J Pathol, 2001, 159(5) : 1917-1924.
8Belaud Rotureau MA, Pattens M, Dubus P, et al. A comparative analysis of FISH, RT-PCR, PCR, and immunohlstochemistry for the diagnosis of mantle cell lymphomas[J]. Mod Pathol, 2002, 15(5) :517-525.
9Elnenaei MO, Jadayel DM, Matutes E, et al. Cyclin D1 by flow cytornetry as a useful tool in the diagnosis of B-cell malignancies[J]. Leuk Res, 2001, 25(2): 115-123.
10Kbeo ML, Ezzat S, Freeman JL, et al. Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary, micrcwarcinornas but is not associated with gene amplification[J]. J Clin Endocrinol Metab, 2002, 87(4) : 1810-1813.
